Medication management and treatment adherence in Parkinson's disease patients with mild cognitive impairment.
Betul Sumbul-SekerciHasmet A HanagasiBasar BilgiçZeynep TüfekçioğluHakan I GürvitMurat EmrePublished in: Acta neurologica Belgica (2022)
Mild cognitive impairment in patients with PD adversely affects medication management. Diagnosing MCI in PD is important to ensure that the appropriate measures can be taken to provide support and improve the medication management process. Adherence assessments based on self-reporting may not provide reliable and sensitive information in patients with PD-MCI.